n CME : Your SA Journal of CPD - Pharm info
|Article Title||Pharm info|
|© Publisher:||Health and Medical Publishing Group (HMPG)|
|Journal||CME : Your SA Journal of CPD|
|Publication Date||Mar 2004|
Extracted from text ... Patients taking Pfizer Inc's cholesterol-lowering medicine Lipitor (atorvastatin calcium) experienced a significant reduction in the progression of atherosclerosis compared with patients who received Prava (pravastatin), according to new data presented at the annual meeting of the American Heart Association in Orlando, Florida, in November 2003. The Reversing Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) study followed up 502 patients who were diagnosed with coronary heart disease and required cardiac catheterisation or angiograms. Patients in the 18- month study had at least one arterial vessel with 20% or more constriction due to plaque build-up. The study compared the effectiveness of Lipitor (80 ..
Article metrics loading...